Related Experiment Video
Updated: May 7, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Factors related with the progression of chronic kidney disease
Insights
Chronic kidney disease (CKD) progression is linked to higher phosphate, PTH, and proteinuria levels. Managing these bone and mineral metabolism factors may slow kidney function decline.
Area of Science:
- Nephrology
- Bone and Mineral Metabolism
- Chronic Kidney Disease Research
Background:
- Understanding chronic kidney disease (CKD) progression is crucial for patient outcomes.
- Bone and mineral metabolism plays a significant role in advanced CKD.
- Identifying predictors of CKD progression is essential for targeted interventions.
Purpose of the Study:
- To determine the rate of progression in advanced chronic kidney disease (CKD).
- To identify key predictors of CKD progression, focusing on bone and mineral metabolism.
- To analyze the relationship between eGFR decline and metabolic factors.
Main Methods:
- Retrospective observational study of 300 patients with advanced CKD.
- Analysis of estimated glomerular filtration rate (eGFR) decline over a mean follow-up of 19.4 months.
- Assessment of serum phosphate, calcium, PTH, and proteinuria as potential predictors.
Main Results:
- Mean eGFR decline was -1.64 mL/min/1.73 m²/year.
- eGFR decline correlated inversely with serum phosphate, PTH, and proteinuria.
- Serum phosphate, PTH, and proteinuria were significant predictors in multivariate analysis.
Conclusions:
- The rate of eGFR decline in CKD is associated with serum phosphate, PTH levels, and proteinuria.
- These identified factors are modifiable through appropriate treatment strategies.
- Targeting bone and mineral metabolism may help manage CKD progression.
Background:
Our aims were to determine the rate of progression of chronic kidney disease (CKD) and to identify predictors, with particular emphasis on bone and mineral metabolism.
Methods:
Retrospective and observational study including 300 patients with advanced CKD (61.2% males, 33.1% diabetics; age 65.6±14 years). Mean follow-up time was 19.4±10.1 months. Baseline estimated glomerular filtration rate (eGFR) (MDRD-4) was 22.5±7.18 mL/min. To calculate the rate of decline in eGFR, we used the slope of the regression line between all determinations of eGFR and follow-up time. We calculated the mean values for proteinuria and serum phosphate, calcium, uric acid, and PTH, as well as 24-hour urinary excretion of urea nitrogen over time for each patient. Follow-up was at least 6 months and included at least 4 measurements of eGFR.
Results:
The mean rate of decline eGFR (-1.64 mL/min/1.73 m²/year) was inversely correlated with serum phosphate levels (4.3±2.1 mg/dL, P<.001), PTH (256.3±193.7 ng/L, p<.001) and proteinuria (0.84±1.31 g/day, P=.004) and directly correlated with mean serum calcium (P<.001) and the presence of hypertension (P<.02). However, only serum phosphate, serum PTH, and proteinuria persisted as predictors in the multivariate analysis. Stable-GFR patients (positive slope) were older (P=.041) and had lower serum phosphate and PTH levels (P<.01 and P<.01 respectively) and lower proteinuria (P<.01).
Conclusions:
The rate of decrease in eGFR was correlated with serum phosphate and PTH levels and proteinuria. All of these factors can be modified with an adequate treatment.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Diabetic Nephropathy
